← The SEC Ephemeris: the whole map
Heron Therapeutics, Inc. Zynrelef
In the graph: all 35 documents (217 pages).
- Application
- NDA 211988
- Ticker
- HRTX
- Product
- Zynrelef
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- June 26, 2020 · April 30, 2019
From FDA letters and SEC filings. Not investment or medical advice.